Author Archives: thomas
GR mobility: JCS 132, 2019
Keizer VIP, Coppola S, Houtsmuller AB, Geverts B, van Royen ME, Schmidt T, Schaaf MJM. Repetitive switching between DNA-binding modes enables target finding by the glucocorticoid receptor. J Cell Sci. 2019 Feb 25;132(5). pii: jcs217455. [DOI] [pdf]
hERG and cytoskeleton in PDAC: Cancer 23, 2019
Manoli S, Coppola S, Duranti C, Lulli M, Magni L, Kuppalu N, Nielsen N, Schmidt T, Schwab A, Becchetti A, Arcangeli A. The Activity of Kv 11.1 Potassium Channel Modulates F-Actin Organization During Cell Migration of Pancreatic Ductal Adenocarcinoma Cells. … Continue reading
Olga landed a job with ASML –
Olga will now develop XUV-machines at ASML.
Force vs shape: Phys.Rev.Lett. 121, 2018
Pomp W, Schakenraad K, Balcıoğlu HE, van Hoorn H, Danen EHJ, Merks RMH, Schmidt T, Giomi L. Cytoskeletal Anisotropy Controls Geometry and Forces of Adherent Cells. Phys Rev Lett. 2018 Oct 26; 121(17):178101. [DOI] [pdf]
Julia joined the team –
Julia joined the team for her PhD on mechanics in metastasis. Welcome!
Mechanopharmacology: DRU, 31, 2017
Coppola S, Carnevale I, Danen EHJ, Peters GJ, Schmidt T, Assaraf YG, Giovannetti E (2017) A mechanopharmacology approach to overcome chemoresistance in pancreatic cancer., Drug Resist. Updat., 31, 43-51. [DOI] [pdf] Pancreatic ductal adenocarcinoma (PDAC) is a highly chemoresistant malignancy. … Continue reading
IL4 microdomains: Nat Comm, 8, 2017
Richter D, Moraga I, Winkelmann H, Birkholz O, Wilmes S, Schulte M, Kraich M, Kenneweg H, Beutel O, Selenschik P, Paterok D, Gavutis M, Schmidt T, Garcia KC, Müller TD, Piehler J (2017) Ligand-induced type II interleukin-4 receptor dimers are … Continue reading
hERG1 channels in PDAC, Science Signaling, 10, 2017
Becchetti A, Crescioli S, Zanieri F, Petroni G, Mercatelli R, Coppola S, Gasparoli L, D’Amico M, Pillozzi S, Crociani O, Stefanini M, Fiore A, Carraresi L, Morello V, Manoli S, Brizzi MF, Ricci D, Rinaldi M, Masi A, Schmidt T, … Continue reading
